Abstract: The present invention includes a system and process for monitoring the transmission of secured, marked digital files. A cryptographic token inertly embedded in markup language tags of digital files is sought at a transmission gateway.

Abstract: It is described an electronic system (50) to drive an electric device (5) of a bicycle assisted electrically (1) by means of a rechargeable battery (6). In case of detecting that the calculated human power is greater than or equal to the bicycle estimated friction power and in case of detecting that the state of charge of the battery (6) is greater than or equal to a first threshold, the processor is such to generate a driving current value for driving the electric device (5) operating as an electric motor (5) supplied from the battery (6). In case of detecting that the calculated human power is smaller than the estimated bicycle friction power, the processor is such to convert at least part of the human power into electric power by means of the electric device (5) operating as an electric generator (5), and generate therefrom another driving current value for charging the battery (6) from the electric device operating as electric generator.

Abstract: A tool bit having a first end, a second end including an engagement portion for engaging a tool, a shank extending longitudinally between the tip and the engagement portion, and a spring, the spring being fixed to the shank in a manner such that the spring remains in a substantially static position while the tool bit is in use.

Abstract: The invention relates to an optical pumping device comprising: a fibre light source emitting controlled radiation having a very high transverse modal quality, with a wavelength shorter than 1000 nm; at least one element consisting of an amplifying material doped with a rare earth dopant; means for introducing a pumping light into said doped amplifying material element; and means for cooling said amplifying material. Said optical pumping device is characterised in that the pumping light is emitted by the fibre light source with an average power of higher than 2 W and a modal quality characterised by an M2<5 factor.

Abstract: When a reverse reproduction is instructed, an MPEG video stream is once decoded and is converted to image video signals by a first display circuit. Thereafter, the image video signals are again recoded by an image input circuit and an MPEG video encoder, so as to be overwritten in a storage area of a hard disk. An MPEG video decoder reads out this recoded data sequence in a reverse time-series manner and decodes it successively. Then the thus decoded data are converted to image video signals by a second display circuit, so as to be displayed on a display.

Abstract: The invention relates to an apparatus for a checkpoint, comprising a controlled access passage, the exit of which is closed by an exit door (gate). Said exit door (5) opens in response to a signal of a least one biometric unit (8) which is arranged in the controlled access space (3) and by which the biometric features of a person desiring passage can be detected, and said biometric unit (8) is arranged frontally opposite of the entrance to the controlled access space (3) and preferably integrated in the exit door (5) of the controlled access space (3). A person entering the controlled access space (3) is therefore immediately located quasi automatically in the correct position for detection by the biometric unit (8), which is to say, frontally opposite of the biometric unit.

Abstract: The present patent application relates to a method for diagnosing angioedema with a gain-of-function mutation of kinin formation, and for determining the amount of BK or des-Arg9 -BK antagonist required for halting the effects of angioedema, from a plasma sample of a patient. The invention also relates to a kit for said determination.

Abstract: The present invention relates to a pharmaceutical composition including a modified factor Xa (GDXa), said modified GDXa being nonthrombogenic, able to bind to TFPI but not able to bind to phospholipids, for preventing or treating a hemorrhagic accident in a patient with hemophilia A or B with or without inhibitor.

Abstract: The present invention provides a novel therapeutic combination comprising one or more anti-androgen agents and one or more antibiotic/anti-inflammatory agents or pharmaceutically acceptable salts or hydrates thereof, useful for the treatment of a dermatological disorder.

Abstract: A computer system comprising one or more communications devices; one or more processors operatively connected to the one or more communications devices; and one or more computer readable media operatively connected to the one or more processors and having stored thereon computer instructions for carrying out the steps of (a) maintaining, by the computer system, a database comprising (1) first data related to identification of one or more works; and (2) second data related to information corresponding to each of the one or more works as identified by the first data; (b) obtaining, by the computer system, extracted features of a work to be identified; (c) identifying, by the computer system, the work by comparing the extracted features of the work with the first data in the database using a non-exhaustive neighbor search; (d) determining, by the computer system, the information corresponding to the identified work based on the second data in the database; and (e) associating, by the computer system, the determi

Abstract: A system for aiding in the positioning of a medical instrument on the head of a patient, characterized in that it includes a means for predicting the location of a target intracranial area of the medical instrument, comprising a generic three-dimensional model of a head comprising a scalp and a generic target intracranial area, a three-dimensional working image of the scalp of the head of the patient, surface registration means suitable for establishing a registration transform from the scalp of the generic model toward the working image of the scalp of the head of the patient, a means for resampling the generic target intracranial area into a converted target area using with the registration transform, and a means for locating the target intracranial area of the patient from the locating of the converted target area, thereby enabling the positioning of the medical instrument on the head of the patient.

Abstract: The present invention relates to compounds of formula (I), where R1 and R2, identical or different, are each independently a hydrogen atom or a non-substituted or substituted (C1-C12) alkyl group; R3 is a hydrogen atom or a non-substituted or substituted (C1-C6) alkyl group; R4 is a non-substituted or substituted (C1-C12) alkyl group or an aryl or heteroaryl group, said aryl and heteroaryl groups being non-substituted or substituted; and R5 is a non-substituted or substituted (C1-C12) alkyl group; or R4 and R5 are bonded to one another by a saturated hydrocarbon chain having 3 or 4 carbon atoms, optionally in hydrated form or in the form of a salt that is acceptable for being administered to animals or plants, for the use thereof as a potentiator of the effect of an antimicrobial agent or for the use thereof as an antimicrobial agent.

Abstract: A method is provided for controlling a converter of the multiphase interleaving type. According to the method, there is detected when a change of the load applied to an output terminal of the converter occurs. All the phases of the converter are simultaneously turned off, and a driving interleaving phase shift is recovered so as to restart a normal operation of the converter. A controller for carrying out such a method is also provided.

Abstract: The device for closing openings or cavities in blood vessels, e.g. in veins or in the heart, said device comprises a closing body comprising an outer side having a partial region arranged for blood flow therealong at least in a part of said partial region thereof when said closing body is in its state of use for closing said opening or cavity.

Abstract: Dissymmetric particles also called Janus particles of micron or submicron size and methods of synthesis of Janus particles by bipolar electrochemistry, based on substrates of isotropic or anisotropic shape. The particles include an electrically conductive substrate having at least a chemically and/or physically modified part by deposit of a layer of electrochemically depositable material, and a non-modified part. The particles are of isotropic shape, and the layer of electrochemically depositable material has a specific shape delimited by a precise contour.

Abstract: The present invention relates to methods and pharmaceutical compositions for inhibiting influenza virus replication. More particularly, the present invention relates to a compound selected from the group consisting of Gemcitabine, Obatoclax Mesylate, Docetaxel, HA-14, Alsterpaullone, GSK3B inhibitor VIII, GSK3B inhibitor XV, Indirubin 3?- monoxime, L glutathione reduced, Fluocinolone acetonide, Tirofiban, Topotecan hydrochloride, Clofarabine, Vinblastine, Menadione Crystalline and derivatives or analogues thereof for use in the treatment of an influenza infection in a subject in need thereof.

Abstract: A computer-implemented method including the steps of maintaining, by a computer system including at least one computer, a database in which is stored first data related to identification of one or more works and second data related to information corresponding to each of the one or more works as identified by the first data. Extracted features of a work to be identified are obtained. The work is identified by comparing the extracted features of the work with the first data in the database using a non-exhaustive neighbor search. The information corresponding to the identified work is determined based on the second data in the database. The determined information is associated with the identified work.

Abstract: The present invention relates to methods for increasing the replication capacity of an influenza virus in cultured cells. More particularly, the present invention relates to a method for increasing the replication capacity of an influenza virus in a cell comprising the steps consisting of i) infecting said cell with said influenza virus and ii) culturing said infected cell with a least one molecule selected from the group consisting of Dibucaine, Aprindine, Amiloride, Mevinolin, Simvastatin, Promathazine, Pranlukast, Nimodipine, Ibutilide hemifumarate Salt, Risperidone and derivatives or analogues thereof.

Abstract: An image destruct material comprises a release layer positioned between an image receiving layer and a base layer. The adhesion between the release layer and the base layer is greater than adhesion between the release layer and the image receiving layer. The release layer material can be used in secure documents that have an image receiving layer. After information is printed on the image receiving layer, an overlaminate is applied over it. Removal of the overlaminate destroys the printed image on the receiving layer because of the relative adhesive properties of the image receiving layer, overlaminate and release layer.

Abstract: A polychrome electrophoretic ink including at least four types of particles dispersed in a nonpolar organic medium, each particle type containing a pigment of a color which is associated therewith, having a positive or negative electrostatic charge, characterized in that at least one of the abovementioned particle types has a magnetic property (magnetic core) such that each particle type can migrate in a predetermined manner under the combined action of an electrostatic force and of a magnetic return force.